Pamela Chu

611 total citations
22 papers, 396 citations indexed

About

Pamela Chu is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Pamela Chu has authored 22 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 10 papers in Surgery and 9 papers in Obstetrics and Gynecology. Recurrent topics in Pamela Chu's work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Endometriosis Research and Treatment (5 papers). Pamela Chu is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Endometriosis Research and Treatment (5 papers). Pamela Chu collaborates with scholars based in Canada, United States and India. Pamela Chu's co-authors include Jill Nation, Prafull Ghatage, Gregg Nelson, Alon D. Altman, Steve E. Kalloger, Martin Köbel, Sarah Glaze, Steven Bisch, Anthony M. Magliocco and Tiffany Wells and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Gynecologic Oncology.

In The Last Decade

Pamela Chu

21 papers receiving 391 citations

Peers

Pamela Chu
Nicholas P. Taylor United States
Sandra Beare United Kingdom
Lihui Han China
Amanda L. Kansler United States
Emily Prendergast United States
Nicholas P. Taylor United States
Pamela Chu
Citations per year, relative to Pamela Chu Pamela Chu (= 1×) peers Nicholas P. Taylor

Countries citing papers authored by Pamela Chu

Since Specialization
Citations

This map shows the geographic impact of Pamela Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Chu more than expected).

Fields of papers citing papers by Pamela Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Chu. The network helps show where Pamela Chu may publish in the future.

Co-authorship network of co-authors of Pamela Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Chu. A scholar is included among the top collaborators of Pamela Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Chu. Pamela Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Pamela, et al.. (2024). Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysis. International Journal of Gynecological Cancer. 34(6). 855–862. 1 indexed citations
2.
Ghosh, Sunita, et al.. (2021). Venous Thromboembolism in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian Cancer and Impact on Survival. Journal of Obstetrics and Gynaecology Canada. 43(12). 1380–1387. 8 indexed citations
3.
Nelson, Gregg, et al.. (2020). Cytology positive pericardial effusion causing tamponade in patients with high grade serous carcinoma of the ovary. Gynecologic Oncology Reports. 33. 100621–100621.
4.
Bisch, Steven, Sarah Glaze, A. T. Cameron, et al.. (2019). Impact of transversus abdominis plane blocks versus non-steroidal anti-inflammatory on post-operative opioid use in ERAS ovarian cancer surgery. International Journal of Gynecological Cancer. 29(9). 1372–1376. 10 indexed citations
5.
Cameron, A. T., et al.. (2019). Universal Testing to Identify Lynch Syndrome Among Women With Newly Diagnosed Endometrial Carcinoma. Journal of Obstetrics and Gynaecology Canada. 42(2). 137–143. 6 indexed citations
6.
Bisch, Steven, Tiffany Wells, Leah Gramlich, et al.. (2018). Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes. Gynecologic Oncology. 151(1). 117–123. 105 indexed citations
7.
Altman, Alon D., Gregg Nelson, Prafull Ghatage, et al.. (2013). The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors. Modern Pathology. 26(9). 1255–1263. 41 indexed citations
8.
Altman, Alon D., Xiaoqing Liu, Gregg Nelson, et al.. (2013). The Effects of Anemia and Blood Transfusion on Patients With Stage III–IV Ovarian Cancer. International Journal of Gynecological Cancer. 23(9). 1569–1576. 22 indexed citations
9.
Glaze, Sarah, et al.. (2013). Dose-Dense Paclitaxel With Carboplatin for Advanced Ovarian Cancer: A Feasible Treatment Alternative. Journal of Obstetrics and Gynaecology Canada. 35(1). 61–67. 5 indexed citations
10.
Bromley, Amy, Alon D. Altman, Pamela Chu, et al.. (2012). Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma. International Journal of Gynecological Pathology. 31(5). 397–404. 18 indexed citations
11.
Altman, Alon D., Gregg Nelson, Pamela Chu, Jill Nation, & Prafull Ghatage. (2012). Optimal Debulking Targets in Women With Advanced Stage Ovarian Cancer: A Retrospective Study of Immediate Versus Interval Debulking Surgery. Journal of Obstetrics and Gynaecology Canada. 34(6). 558–566. 8 indexed citations
12.
Chu, Pamela, et al.. (2012). The risk of diagnostic hysteroscopy in women with endometrial cancer. American Journal of Obstetrics and Gynecology. 207(1). 71.e1–71.e5. 18 indexed citations
13.
Altman, Alon D., Gregg Nelson, Pamela Chu, Jill Nation, & Prafull Ghatage. (2012). Uterine Sarcoma and Aromatase Inhibitors. International Journal of Gynecological Cancer. 22(6). 1006–1012. 28 indexed citations
14.
Klimowicz, Alexander C., Michelle L. Dean, Pamela Chu, et al.. (2012). Quantification of ER/PR expression in ovarian low-grade serous carcinoma. Gynecologic Oncology. 128(2). 371–376. 56 indexed citations
15.
Altman, Alon D., Jennifer Thompson, Gregg Nelson, et al.. (2012). Use of Aromatase Inhibitors as First-and Second-Line Medical Therapy in Patients With Endometrial Adenocarcinoma: A Retrospective Study. Journal of Obstetrics and Gynaecology Canada. 34(7). 664–672. 11 indexed citations
16.
Altman, Alon D., Gregg Nelson, Jill Nation, Pamela Chu, & Prafull Ghatage. (2011). Vacuum Assisted Wound Closures in Gynaecologic Surgery. Journal of Obstetrics and Gynaecology Canada. 33(10). 1031–1037. 9 indexed citations
18.
Yau, Annie, et al.. (2010). Cutaneous Metastatic Disease in Cervical Cancer: A Case Report. Journal of Obstetrics and Gynaecology Canada. 32(5). 467–472. 26 indexed citations
19.
Chebib, Ivan, Pamela Chu, Máire A. Duggan, & Lisa Difrancesco. (2010). Primary Signet-ring Cell Adenocarcinoma of the Endometrium: Case Report and Review of the Literature. International Journal of Gynecological Pathology. 29(3). 269–272. 8 indexed citations
20.
Nation, Jill, et al.. (2009). Malignant Chest Wall Endometriosis: A Case Report and Literature Review. Journal of Obstetrics and Gynaecology Canada. 31(6). 538–541. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026